Changes in gingival hyperplasia were studied in 48 patients treated for epilepsy with diphenylhydantoin (DPH) over a two-year period. During this time changes in the dose of DPH were made in some patients in order to increase control of seizures or decrease side-effects: in 27 patients the dose was increased, in nine it was decreased and in 12 the dose remained unchanged. It was found that the severity of gingival hyperplasia varied directly with both the dose and serum level of the drug.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1469-8749.1975.tb03492.x | DOI Listing |
Publication Analysis
Top Keywords
gingival hyperplasia
12
diphenylhydantoin-induced gingival
4
hyperplasia response
4
response changes
4
changes drug
4
drug dosage
4
dosage changes
4
changes gingival
4
hyperplasia studied
4
studied patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!